Glucuronidation of diflunisal in liver and kidney microsomes of rat and man

Xenobiotica

Volumn 26, Issue 2, 1996, Pages 123-131

  Brunelle, F M ^a   Verbeeck, R K ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCURONIDASE; DIFLUNISAL; DRUG METABOLITE; GLUCURONOSYLTRANSFERASE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG GLUCURONIDATION; DRUG METABOLISM; HUMAN; HUMAN TISSUE; KIDNEY MICROSOME; LIVER MICROSOME; MALE; NONHUMAN; RAT;

ANIMALIA;

EID: 0029923354     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.3109/00498259609046694     Document Type: Article

References (36)

1. AMAR-COSTESEC, A., BEAUFAY, H., WIBO, M., THINÈS-SEMPOUX, D., FEYTMANS, E., ROBBI, M., and BERTHET, J., 1974, Analytical study of microsomes and isolated subcellular membranes from rat liver. Journal of Cell Biology, 61, 201-212.
2. BRUNELLE, F. M., RAOOF, A. A., DE VILLE DE GOYET, J., and VERBEECK, R. K., 1996, Glucuronidation of diflunisal, (-)-morphine, 4-nitrophenol and propofol in liver microsomes of two patients with Crigler Najjar Syndrome type I. Biopharmaceutics and Drug Disposition (in press).
3. BRUNELLE, F. M., and VERBEECK, R. K., 1993, Glucuronidation of diflunisal by rat liver microsomes. Effect of microsomal β-glucuronidase activity. Biochemical Pharmacology, 46, 1953-1958.
4. BURCHELL, B., COUGHTRIE, M. W. H., and JANSSEN, P. L. M., 1994, Function and regulation of UDP-glucuronosyltransferase genes in health and liver disease. Report of the 7th International Workshop on Glucuronidation, September 1993, Pitlochry, UK. Hepatology, 20, 1622-1630.
5. CAPIELLO, M., GIULIANI, L., and PACIFICI, G. M., 1991, Distribution of UDP-glucuronosyltransferase and its endogenous substrate uridine 5′-diphosphoglucuronic acid in human tissues. European Journal of Clinical Pharmacology, 41, 345-350.
6. CLARKE, D. J., and BURCHELL, B., 1994, The uridine diphosphate glucuronosyl-transferase multigene family: function and regulation. In Conjugation-Deconjugation Reactions in Drug Metabolism and Toxicity, edited by F. C. Kauffman (Berlin: Springer), pp. 3-43.
7. DICKINSON, R. G., and KING, A. R., 1989, Reactivity considerations in the analysis of glucuronide and sulfate conjugates of diflunisal. Therapeutic Drug Monitoring, 11, 712-720.
8. DICKINSON, R. G., VERBEECK, R. K., and KING, A. R., 1991, Absence of phenotic glucuronidation and enhanced hydroxylation of diflunisal in the homozygous Gunn rat. Xenobiotica, 21, 1535-1546.
9. DUTTON, G. J., 1980, Glucuronidation of Drugs and Other Compounds (Boca Raton: CRC Press).
10. DWIVEDI, C., DOWNIE, A. A., and WEBB, T. E., 1987, Net glucuronidation in different rat strains: importance of microsomal β-glucuronidase. FASEB Journal, 1, 303-307.
11. EBNER, T., and BURCHELL, B., 1993, Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family. Drug Metabolism and Disposition, 21, 50-55.
12. FEVERY, J., VAN DE VIJVER, M., MICHIELS, R., and HEIRWEGH, K. P. M., 1977, Comparison in different species of biliary bilirubin-IXa conjugates with the activities of hepatic and renal bilirubin-IXa-uridine diphosphate glycosyltransferases. Biochemical Journal, 164, 737-764.
13. GREEN, M. D., BISHOP, W. P., and TEPHLY, T. R., 1995, Expressed human UGT1,4 protein catalyzes the formation of quaternary ammonium-linked glucuronides. Drug Metabolism and Disposition, 23, 299-302.
14. HEIRWEGH, K. P. M., VAN DE VIJVER, M., and FEVERY, J., 1972, Assay and properties of digitonin-activated bilirubin uridine diphosphate glucuronyltransferase from rat liver. Biochemical Journal, 129, 605-618.
15. KAUFFMAN, F. C., 1994, Regulation of drug conjugate production by futile cycling in intact cells. In Conjugation-Deconjugation Reactions in Drug Metabolism and Toxicity, edited by F. C. Kauffman (Berlin: Springer), pp. 245-255.
16. KRISHNA, D. R., and KLOTZ, U., 1994, Extrahepatic metabolism of drugs in humans. Clinical Pharmacokinetics, 26, 144-160.
17. KROEMER, H. K., and KLOTZ, U., 1992, Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors. Clinical Pharmacokinetics, 23, 293-310.
18. LEAR, L., NATION, R. L., and STUPANS, I., 1991, Influence of morphine concentration on detergent activation of rat liver morphine-UDP-glucuronosyltransferase. Biochemical Pharmacology, 42, S55-S60.
19. LIN, J. H., HOOKE, K. F., YEH, K. C., and DUGGAN, D. E., 1985, Dose-dependent pharmacokinetics of diflunisal in rats: dual effects of protein binding and metabolism. Journal of Pharmacology and Experimental Therapeutics, 235, 402-406.
20. LOEWEN, G. R., MACDONALD, J. I., and VERBEECK, R. K., 1984, High-performance liquid chromatographic method for the simultaneous quantitation of diflunisal and its glucuronide and sulfate conjugates in human urine. Journal of Pharmaceutical Sciences, 78, 250-255.
21. LOWRY, O. H., ROSENBROUGH, N. J., FARR, A. L., and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265-275.
22. MARSELOS, M., DUTTON, G., and HÄNNINEN, O., 1975, Evidence that D-glucaro-1,4-lactone shortens the pharmacological action of drugs being disposed via the bile as glucuronides. Biochemical Pharmacology, 24, 1855-1858.
23. MAZOIT, J. X., SANDOUK, P., SCHERRMANN, J.-M., and ROCHE, A., 1990, Extrahepatic metabolism of morphine occurs in humans. Clinical Pharmacology and Therapeutics, 48, 613-618.
24. MINERS, J. O., and MACKENZIE, P. I., 1991, Drug glucuronidation in humans. Pharmacology and Therapeutics, 51, 347-369.
25. MULDER, G. J., 1992, Glucuronidation and its role in regulation of biological activity of drugs. Annual Review of Toxicology, 32, 25-49.
26. +-linked assay for microsomal uridine diphosphate glucuronyltransferase of rat liver and some observations on substrate specificity of the enzyme. Biochemical Journal, 151, 131-140.
27. PRITCHARD, M., FOURNEL-GIGLEUX, S., SIEST, G., MACKENZIE, P., and MAGDALOU, J., 1994, A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols and carboxylic acids. Molecular Pharmacology, 45, 42-50.
28. SPAHN-LANGGUTH, H., and BENET, L. Z., 1993, Microsomal acyl glucuronidation: enzyme-kinetic studies with labile glucuronides. Pharmacology, 46, 28-273.
29. SUTHERLAND, L., EBNER, T., and BURCHELL, B., 1993, The expression of UDP-glucuronosyltransferases of the UGT1 family in human liver and kidney and in response to drugs. Biochemical Pharmacology, 45, 295-301.
30. TOCCO, D. J., BREAULT, G. O., ZACCHEI, A. G., STEELMAN, S. L., and PERRIER, C. V., 1975, Physiological disposition and metabolism of 5-(2′,4′-difluorophenyl)salicyclic acid, a new salicylate. Drug Metabolism and Disposition, 6, 453-466.
31. TOMASIC, J., and KEGLEVIC, D., 1973, The kinetics of hydrolysis of synthetic glucuronide esters and ethers by bovine liver and Escherichia coli β-glucuronidase. Biochemical Journal, 133, 789-795.
32. VERBEECK, R. K., LOEWEN, G. R., MACDONALD, J. I., and HERMAN, R. J., 1990, The effect of multiple dosage on the kinetics of glucuronidation and sulphation in man. British Journal of Clinical Pharmacology, 29, 381-389.
33. WALASZEK, Z., 1990, Potential use of D-glucaric acid derivatives in cancer prevention. Cancer Letters, 54, 1-8.
34. WALASZEK, Z., HANAUSEK-WALASZEK, M., and WEBB, T. E., 1984, Inhibition of 7,12-dimethyl-benzanthracene-induced rat mammary tumorigenesis by 2,5-di-O-acetyl-D-glucaro-1,2:6,3-dilactone, an in vivo β-glucuronidase inhibitor. Carcinogenesis, 5, 767-772.
35. WALASZEK, Z., HANAUSEK-WALASZEK, M., and WEBB, T. E., 1986, Dietary glucarate-mediated reduction of sensitivity of murine strains to chemical carcinogenesis. Cancer Letters, 33, 25-32.
36. WHITING, J. F., NARCISO, J. P., CHAPMAN, V., RANSIL, B. J., SWANK, R. T., and GOLLAN, J. L., 1993, Deconjugation of bilirubin-IXα glucuronides: a physiologic role of hepatic microsomal β-glucuronidase. Journal of Biological Chemistry, 268, 23197-23201.